Once-a-day Immunosuppression(CISECON_a_day)
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 160 participants.
Also called NCT01964014
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 160 participants
- Registry
-
NCT01964014
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT01964014. Allocation not applicable; no masking; primary purpose treatment. Start 2013-10 (registry gives no type); primary completion 2015-10 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Once-a-day Immunosuppression(CISECON_a_day)
- Acronym
- CISECON
- Condition
- Chronic Renal Disease
- Intervention (Drug)
- advagrf
- Lead sponsor
- Ajou University School of Medicine
Record details
- Record id
cardio:ct-nct01964014- Content hash
e2da817e28f7479a411b3594474a43a9aa8092639a15965aaa72641c6dbea76d